|
Ronald E. Blaylock elected to Pfizer's Board of Directors
|
24 February 2017 |
|
Relationship expert teams up with Pfizer to address intimacy and relationship issues for people living with chronic diseases
|
10 February 2017 |
|
Pfizer reports fourth-quarter and full-year 2016 results
|
31 January 2017 |
|
Pfizer announces expansion of ASPIRE awards program for 2017 to include $5.5M in funding for breast and hematologic cancers
|
14 December 2016 |
|
IBM and Pfizer to accelerate immuno-oncology research with Watson for Drug Discovery
|
02 December 2016 |
|
Pfizer's Prevenar 13® receives approval for use in infants and children in China
|
02 November 2016 |
|
Pfizer awarded grant to evaluate vaccine to protect newborns against group B Streptococcus infection
|
19 October 2016 |
|
Pfizer decides remaining one company best positions company to maximize future value creation
|
26 September 2016 |
|
Pfizer launches new "Moodivator" app to help support, encourage and motivate people with depression
|
14 September 2016 |
|
Pfizer appoints chief scientific officer for neuroscience research
|
08 September 2016 |
|
Pfizer to acquire small molecule anti-infective business from AstraZeneca
|
24 August 2016 |
|
Pfizer announces publication of new analysis showing long-term therapy with VYNDAQEL (tafamidis) slowed progression of rare neurodegenerative disease
|
12 August 2016 |
|
Pfizer aims to become industry leader in gene therapy with acquisition of Bamboo Therapeutics, Inc.
|
02 August 2016 |
|
Pfizer receives World Health Organization prequalification for multi-dose vial presentation of Prevenar 13®
|
19 July 2016 |
|
Merck and Pfizer initiate Phase III trial to evaluate Avelumab as first-line treatment for ovarian cancer
|
07 July 2016 |
|
Pfizer completes acquisition of Anacor
|
24 June 2016 |
|
Help Pfizer change the future of healthy aging
|
21 June 2016 |
|
Pfizer presents promising data from next generation ALK/ROS1 inhibitor in advanced non-small cell lung cancer
|
06 June 2016 |
|
Merck and Pfizer to present Avelumab data in seven different cancers at ASCO annual meeting
|
19 May 2016 |
|
Pfizer awards more than $1 million in metastatic breast cancer research funding
|
13 May 2016 |